相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。New Strategies in HER2-Overexpressing Breast Cancer: Many Combinations of Targeted Drugs Available
Vandana Abramson et al.
CLINICAL CANCER RESEARCH (2011)
MicroRNA-210 Regulates Cancer Cell Proliferation through Targeting Fibroblast Growth Factor Receptor-like 1 (FGFRL1)
Soken Tsuchiya et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Up-regulation of miR-21 Mediates Resistance to Trastuzumab Therapy for Breast Cancer
Chang Gong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
MicroRNAs in body fluids-the mix of hormones and biomarkers
Maria Angelica Cortez et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Circulating microRNAs as Novel Minimally Invasive Biomarkers for Breast Cancer
Helen M. Heneghan et al.
ANNALS OF SURGERY (2010)
The role of hypoxia and acidosis in promoting metastasis and resistance to chemotherapy
Katie DeClerck et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2010)
Reprogramming of miRNA networks in cancer and leukemia
Stefano Volinia et al.
GENOME RESEARCH (2010)
Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival
Thomas Greither et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Role of MicroRNAs in Cardiac Preconditioning
Fadi N. Salloum et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2010)
Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer
Allen S. Ho et al.
TRANSLATIONAL ONCOLOGY (2010)
Her2/neu signaling blockade improves tumor oxygenation in a multifactorial fashion in Her2/neu(+) tumors
Matthew E. Hardee et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
MicroRNA Expression in Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus: Associations with Survival
Ewy A. Mathe et al.
CLINICAL CANCER RESEARCH (2009)
MiR-21 Indicates Poor Prognosis in Tongue Squamous Cell Carcinomas as an Apoptosis Inhibitor
Jinsong Li et al.
CLINICAL CANCER RESEARCH (2009)
The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform
Kimberly E. Resnick et al.
GYNECOLOGIC ONCOLOGY (2009)
Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma
Charles H. Lawrie et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Met receptor contributes to trastuzumab resistance of Her2-overexpressing breast cancer cells
David L. Shattuck et al.
CANCER RESEARCH (2008)
Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases
Xi Chen et al.
CELL RESEARCH (2008)
hsa-miR-210 is induced by hypoxia and is an independent prognostic factor in breast cancer
Carme Camps et al.
CLINICAL CANCER RESEARCH (2008)
Hypoxia response and microRNAs: no longer two separate worlds
Mircea Ivan et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
MicroRNAs modulate the chemosensitivity of tumor cells
Paul E. Blower et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer
John A. Foekens et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Roles of human epidermal growth factor receptor 2, c-jun NH2-terminal kinase, phosphoinositide 3-kinase, and p70 S6 kinase pathways in regulation of cyclin G2 expression in human breast cancer cells
Xiao-Feng Le et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies
Michael D. Mattie et al.
MOLECULAR CANCER (2006)
A microRNA expression signature of human solid tumors defines cancer gene targets
S Volinia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines
Fanyin Meng et al.
GASTROENTEROLOGY (2006)
How microRNAs control cell division, differentiation and death
EA Miska
CURRENT OPINION IN GENETICS & DEVELOPMENT (2005)
MicroRNA gene expression deregulation in human breast cancer
MV Iorio et al.
CANCER RESEARCH (2005)
Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: Results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer
AU Buzdar et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Elevated serum HER-2/neu level predicts decreased response to hormone therapy in metastatic breast cancer
A Lipton et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Insulin-like growth factor-I receptor signaling and resistance to trastuzumab (Herceptin)
YH Lu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification
AD Seidman et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
DJ Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
